PGS Publication: PGP000763

Publication Information (EuropePMC)
Title Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial.
PubMed ID 38533953(Europe PMC)
doi 10.1161/jaha.123.033413
Publication Date March 27, 2024
Journal J Am Heart Assoc
Author(s) Zou RS, Ruan Y, Truong B, Bhattacharya R, Lu MT, Karády J, Bernardo R, Finneran P, Hornsby W, Fitch KV, Ribaudo HJ, Zanni MV, Douglas PS, Grinspoon SK, Patel AP, Natarajan P.
Released in PGS Catalog: Oct. 6, 2025

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported

External PGS Evaluated By This Publication

Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution
GWAS
Dev
Eval
Scoring File (FTP Link)
PGS003725
(GPS_Mult)
PGP000466 |
Patel AP et al. Nat Med (2023)
Coronary artery disease coronary artery disease 1,296,172
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003725/ScoringFiles/PGS003725.txt.gz
PGS002654
(biochemistry_LDLdirect.PolyFun-pred)
PGP000332 |
Weissbrod O et al. Nat Genet (2022)
LDL cholesterol low density lipoprotein cholesterol measurement 274,585
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002654/ScoringFiles/PGS002654.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM023040 PGS003725
(GPS_Mult)
PSS012103|
Multi-ancestry (including European)|
663 individuals
PGP000763 |
Zou RS et al. J Am Heart Assoc (2024)
|Ext.
Reported Trait: Stenosis over 50% OR: 2.39 [1.48, 3.85] age, sex, and the first 10 principal components of ancestry
PPM023041 PGS003725
(GPS_Mult)
PSS012103|
Multi-ancestry (including European)|
663 individuals
PGP000763 |
Zou RS et al. J Am Heart Assoc (2024)
|Ext.
Reported Trait: Visible non calcified plaque or with vulnerable features OR: 1.45 [1.23, 1.72] age, sex, and the first 10 principal components of ancestry
PPM023042 PGS002654
(biochemistry_LDLdirect.PolyFun-pred)
PSS012103|
Multi-ancestry (including European)|
663 individuals
PGP000763 |
Zou RS et al. J Am Heart Assoc (2024)
|Ext.
Reported Trait: Plaque presence (on coronary computed tomography angiography) OR: 1.21 [1.01, 1.44] age, sex, and the first 10 principal components of ancestry
PPM023043 PGS002654
(biochemistry_LDLdirect.PolyFun-pred)
PSS012103|
Multi-ancestry (including European)|
663 individuals
PGP000763 |
Zou RS et al. J Am Heart Assoc (2024)
|Ext.
Reported Trait: partially calcified plaque OR: 1.21 [1.01, 1.45] age, sex, and the first 10 principal components of ancestry
PPM023039 PGS003725
(GPS_Mult)
PSS012103|
Multi-ancestry (including European)|
663 individuals
PGP000763 |
Zou RS et al. J Am Heart Assoc (2024)
|Ext.
Reported Trait: Plaque presence (on coronary computed tomography angiography) OR: 1.42 [1.2, 1.68] age, sex, and the first 10 principal components of ancestry

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS012103 277 individuals African unspecified REPRIEVE
PSS012103 379 individuals European REPRIEVE
PSS012103 6 individuals East Asian REPRIEVE
PSS012103 1 individuals South Asian REPRIEVE